Cargando…
Ryanodine receptor 1-mediated Ca(2+) signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes
BACKGROUND: Uterine serous cancer (USC) is the most common non-endometrioid subtype of uterine cancer, and is also the most aggressive. Most patients will die of progressively chemotherapy-resistant disease, and the development of new therapies that can target USC remains a major unmet clinical need...
Autores principales: | Zhang, Li, Au-Yeung, Chi-Lam, Huang, Chunxian, Yeung, Tsz-Lun, Ferri-Borgogno, Sammy, Lawson, Barrett C., Kwan, Suet-Ying, Yin, Zheng, Wong, Stephen T., Thomas, Vienna, Lu, Karen H., Yip, Kay-Pong, Sham, James S. K., Mok, Samuel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373370/ https://www.ncbi.nlm.nih.gov/pubmed/35953818 http://dx.doi.org/10.1186/s13046-022-02419-w |
Ejemplares similares
-
Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype
por: Hu, Wen, et al.
Publicado: (2020) -
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436
por: Hu, Wen, et al.
Publicado: (2021) -
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression
por: Kwan, Suet-Ying, et al.
Publicado: (2020) -
ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment
por: Au-Yeung, Chi-Lam, et al.
Publicado: (2020) -
Pathogenesis and Clinical Management of Uterine Serous Carcinoma
por: Zhang, Li, et al.
Publicado: (2020)